CryoLife Reports Second Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
CryoLife (CRY) PT Raised to $39 at Needham & Company
July 30, 2021 6:30 AM EDTNeedham & Company analyst Matt Matson raised the price target on CryoLife (NYSE: CRY) to $39.00 (from $38.00) while maintaining a Buy rating.
The analyst commented, "CRY's 2Q21 revenue and EPS beat consensus and management provided 2021 revenue guidance that was above consensus. Constant currency revenue... More
CryoLife (CRY) Tops Q2 EPS by 17c
July 29, 2021 4:52 PM EDTCryoLife (NYSE: CRY) reported Q2 EPS of $0.12, $0.17 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $76.1 million versus the consensus estimate of $70.97 million.
GUIDANCE:
CryoLife sees Q3 2021 revenue of $296-300 million, versus the consensus of $294... More
